RECURRENT MASTITIS: A VERY RARE PRESENTATION OF ANTIPSYCHOTIC-INDUCED HYPERPROLACTINEMIA

Discussion: Upon our review, very few cases of antipsychotic-induced hyperprolactinemia causing mastitis have been reported in the literature, mostly involving Risperidone. Conclusion: Increasing awareness of mastitis as a manifestation of hyperprolactinemia among endocrinologists, breast surgeons,...

Full description

Saved in:
Bibliographic Details
Published inEndocrine practice Vol. 23; p. 177
Main Authors Soni, Lina, Wu, Xiannian, Karam, Jocelyne
Format Journal Article
LanguageEnglish
Published Jacksonville Elsevier Limited 01.04.2017
Subjects
Antipsychotics
Breast cancer
Psychotropic drugs
Online AccessGet full text

Cover

More Information
Summary:Discussion: Upon our review, very few cases of antipsychotic-induced hyperprolactinemia causing mastitis have been reported in the literature, mostly involving Risperidone. Conclusion: Increasing awareness of mastitis as a manifestation of hyperprolactinemia among endocrinologists, breast surgeons, and psychiatrists would help provide conservative management and guide long-term preventive therapy of these patients.
ISSN:1530-891X
1934-2403